BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 8.90% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 8.79% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 6.12% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 5.57% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 5.14% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.86% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 4.80% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.69% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.48% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 4.24% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.82% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 3.59% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.36% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 3.13% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 2.77% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.61% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.31% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 2.22% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 1.94% |
| BFLY | Butterfly Network Inc | Healthcare | Medical Devices | 1.92% |